|
Comparison of high-dose proton radiation therapy vs.
brachytherapy in localized prostate cancer: A case-matched analysis
(October 2006)
Abstract #38, 2006 Prostate Cancer Symposium. Shipley,
Zietman et al. based their conclusion on a comparison between 132 men
(T1-2, PSA < 15) receiving high dose EBRT (79.2 Gy) in trial PROG
95-09 with 132 carefully matched men treated with brachytherapy at MGH:
"High dose EBRT is equivalent to brachytherapy for control of localized
[low- and intermediate-risk] prostate cancer". 5-year results: OS and
metastases free survival was 98% for both groups; bNED 88% and 90% for
EBRT and brachytherapy, respectively.
«
Back to Article List
|
